Leveraging her 19 years of business and technical experience as well as industry relationships she works closely with entrepreneurs to help develop successful businesses. She partners with entrepreneurs in a "hands on" role to help get companies started and financed
She draws upon both technical and business experience daily. “I am privileged to have the opportunity to think deeply and pattern match across a broad range of different technologies and their applications.”
Rowan is a board member of Sequenta and VitaPath Genetics, as well as a board observer at Artemis Health, HealthTap, Pacific Biosciences, Adamas Pharmaceuticals, CardioDx and Tethys Bioscience
Prior to joining Mohr Davidow, Rowan was an early employee at Rosetta Inpharmatics where she held the position of Director of Business Development. Before the company was acquired by Merck for $620M she established many collaborative partnerships with organizations in the pharmaceutical, agricultural and biotech fields as well as among various research institutions. Previously, Rowan held the position of marketing manager at Incyte Genomics. Rowan holds a Ph.D. in cellular and molecular biology from the MRC Laboratory of Molecular Biology in Cambridge University, UK where she also earned a bachelor's degree with first class honors in Biochemistry. She likes to point out that she sequenced by hand in the dark ages prior to any genome sequencing or access to automated technologies, and never wants to pour a sequencing gel again! She served postdoctoral fellowships at the University of California, San Francisco, as well as at the MRC-Laboratory of Molecular Biology at Cambridge. She has authored more than a dozen scientific articles and patents.